Company page

Castle Biosciences, Inc.

Castle Biosciences, Inc. is a public company listed under the ticker CSTL, operating in the American market. The company has a market capitalization of approximately $637.2 million. Castle Biosciences focuses on developing and commercializing innovative diagnostic tests to improve patient outcomes in cancer care.